Global Injectable Anticoagulants Market 2018 – Sanofi, Genentech (Roche), Boehringer Ingelheim, Pfizer

Global Injectable Anticoagulants Market 2018 – Sanofi, Genentech (Roche), Boehringer Ingelheim, Pfizer

This report studies the global Injectable Anticoagulants market status and forecast, categorizes the global Injectable Anticoagulants market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).

Get Free Sample Report at @ https://www.qymarketinsights.com/report-detail/37200/request-sample

In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.

The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in 2016 is about 55%, and the proportion is in decreasing trend from 2012 to 2016.

Injectable anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of injectable anticoagulants used to treat AF, and the revenue in 2016 is 3400 M USD.

The global Injectable Anticoagulants market is valued at 5490 million US$ in 2017 and will reach 6820 million US$ by the end of 2025, growing at a CAGR of 2.8% during 2018-2025.

The major manufacturers covered in this report

  • Sanofi
  • Genentech (Roche)
  • Boehringer Ingelheim
  • Pfizer
  • The Medicines Company
  • Aspen
  • Otsuka

Read Complete Report with TOC: https://www.qymarketinsights.com/report/global-injectable-anticoagulants-market-research-report-2018-37200.html

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

  • Low-molecular-weight Heparin (LMWH)
  • Direct Thrombin Inhibitor (DTI)
  • Other

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

  • VTE
  • ACS/MI
  • AF
  • Other

The study objectives of this report are:

To analyze and study the global Injectable Anticoagulants sales, value, status (2013-2017) and forecast (2018-2025).

Focuses on the key Injectable Anticoagulants manufacturers, to study the sales, value, market share and development plans in future.

Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

To define, describe and forecast the market by type, application and region.

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

SEO and attentive market research analyst and consistently obliges to introduce and improve existing business strategies and draw salutary lessons from each project. Expertise in search engine friendly web services which appeals users.

Share this post

Post Comment